Variables | DFS | OS | ||||
---|---|---|---|---|---|---|
HR | 95% CI | p value | HR | 95% CI | p value | |
Univariate analysis | ||||||
 4.1B expression (Positive vs. Negative) | 2.654 | 1.626–4.332 | < 0.001* | 2.547 | 1.584–4.095 | < 0.001* |
 Age (< 65 years vs. ≥ 65 years) | 1.092 | 0.676–1.766 | 0.719 | 0.879 | 0.551–1.400 | 0.586 |
 Gender (male vs. female) | 0.910 | 0.558–1.482 | 0.704 | 0.953 | 0.593–1.530 | 0.841 |
 HP infection (Positive vs. Negative) | 1.131 | 0.699–1.832 | 0.616 | 1.161 | 0.726–1.857 | 0.533 |
 Tumor size (<5 cm vs. ≥ 5 cm) | 1.993 | 1.230–3.230 | 0.005* | 2.260 | 1.403–3.640 | 0.001* |
 Tumor location (Cardia+body vs. Antrum +Whole) | 1.413 | 0.872–2.289 | 0.160 | 1.374 | 0.861–2.194 | 0.183 |
 WHO classification (Tubular +Signet-ring cell vs. Mucinous+ Others) | 1.247 | 0.770–2.022 | 0.369 | 1.128 | 0.705–1.805 | 0.616 |
 Pathologic differentiation (G1 + G2 vs. G3) | 1.229 | 0.867–1.742 | 0.247 | 1.066 | 0.771–1.473 | 0.699 |
 Vascular invasion (Positive vs. Negative) | 1.229 | 0.752–2.010 | 0.411 | 1.142 | 0.709–1.840 | 0.584 |
 Neural invasion (Positive vs. Negative) | 1.213 | 0.748–1.968 | 0.433 | 1.288 | 0.804–2.064 | 0.293 |
 Depth of invasion (T1 + T2 vs. T3 + T4) | 1.429 | 0.814–2.508 | 0.214 | 0.938 | 0.563–1.563 | 0.807 |
 Lymph metastasis (N0 vs. N1 + N2 + N3) | 2.266 | 1.211–4.238 | 0.010* | 1.980 | 1.117–3.512 | 0.019* |
 TNM stage (I + II vs. III) | 2.317 | 1.428–3.760 | 0.001* | 2.578 | 1.657–4.011 | < 0.001* |
Multivariate analysis | ||||||
 4.1B expression (Positive vs. Negative) | 1.773 | 1.036–3.035 | 0.037* | 1.691 | 1.013–2.823 | 0.045* |
 Tumor size (<5 cm vs. ≥ 5 cm) | 1.694 | 1.023–2.803 | 0.040* | 2.025 | 1.242–3.302 | 0.005* |
 Lymph metastasis (N0 vs. N1 + N2 + N3) | 1.724 | 0.903–3.289 | 0.099 | 1.458 | 0.807–2.632 | 0.211 |
 TNM stage (I + II vs. III) | 1.923 | 1.161–3.184 | 0.011* | 2.197 | 1.365–3.534 | 0.001* |